KC
TEVA icon

Kingfisher Capital’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Kingfisher Capital’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-90
Closed -$6K – 244
2015
Q4 		$6K Buy
+90
New +$5.56K ﹤0.01% 252

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Kingfisher Capital's TEVA Position: Q1 2016 in Review

Kingfisher Capital sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q1 2016, closing a stake of 90 shares — an estimated $6K sold.

Kingfisher Capital first reported a position in TEVA in Q4 2015 and held it in 1 quarter. The position peaked at $6K in Q4 2015. 837 funds tracked by Wall St. Rank hold TEVA as of Q1 2016.

  • Kingfisher Capital reported no remaining Teva Pharmaceutical Industries Limited position as of Q1 2016 after selling out during the quarter.
  • Kingfisher Capital sold 90 Teva Pharmaceutical Industries Limited shares in Q1 2016, an estimated $6K.
  • Kingfisher Capital first reported a position in Teva Pharmaceutical Industries Limited in Q4 2015 and held it in 1 quarter.
  • Kingfisher Capital's Teva Pharmaceutical Industries Limited position peaked at $6K in Q4 2015.
  • 837 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q1 2016.

Based on Kingfisher Capital's 13F filing for Q1 2016, filed 13 May 2016.